DANIEL G. WELCH - 15 May 2023 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Director
Signature
Daniel G. Welch, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
NUVB
Transactions as of
15 May 2023
Net transactions value
$0
Form type
4
Filing time
17 May 2023, 17:15:35 UTC
Previous filing
03 May 2023
Next filing
02 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +366,744 $0.000000 366,744 15 May 2023 Class A Common Stock 366,744 $1.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 15, 2024); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.